Order Article Reprints

Destruel P-L, Zeng N, Brignole-Baudouin F, Douat S, Seguin J, Olivier E, Dutot M, Rat P, Dufaÿ S, Dufaÿ-Wojcicki A, et al. In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics. 2020; 12(4):360. https://doi.org/10.3390/pharmaceutics12040360

Destruel, Pierre-Louis, Ni Zeng, Françoise Brignole-Baudouin, Sophie Douat, Johanne Seguin, Elodie Olivier, Melody Dutot, Patrice Rat, Sophie Dufaÿ, Amélie Dufaÿ-Wojcicki, and et al. 2020. "In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics" Pharmaceutics 12, no. 4: 360. https://doi.org/10.3390/pharmaceutics12040360

Destruel, P.-L., Zeng, N., Brignole-Baudouin, F., Douat, S., Seguin, J., Olivier, E., Dutot, M., Rat, P., Dufaÿ, S., Dufaÿ-Wojcicki, A., Maury, M., Mignet, N., & Boudy, V. (2020). In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics, 12(4), 360. https://doi.org/10.3390/pharmaceutics12040360